Skip to Content

Novo Integrated Sciences Inc NVOS

Morningstar Rating
$0.65 −0.02 (2.56%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NVOS is trading within a range we consider fairly valued.
Price
$0.66
Fair Value
$9.39
Uncertainty
Extreme
1-Star Price
$4.65
5-Star Price
$1.86
Economic Moat
Qzpl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NVOS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.67
Day Range
$0.600.71
52-Week Range
$0.425.38
Bid/Ask
$0.60 / $0.62
Market Cap
$12.35 Mil
Volume/Avg
2.1 Mil / 7.2 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.84
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Small Value
Total Number of Employees
230

Valuation

Metric
NVOS
Price/Earnings (Normalized)
Price/Book Value
1.28
Price/Sales
0.84
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NVOS
Quick Ratio
0.17
Current Ratio
0.27
Interest Coverage
−3.03
Quick Ratio
NVOS

Profitability

Metric
NVOS
Return on Assets (Normalized)
−62.86%
Return on Equity (Normalized)
−107.51%
Return on Invested Capital (Normalized)
−63.67%
Return on Assets
NVOS
See how this stock stacks up to its competitors with Morningstar Investor

Medical Care Facilities Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA Healthcare Inc
HCA
GnrzgpsSnmbsw$84.4 Bil
Fresenius SE & Co KGaA ADR
FSNUY
Zbqpg$18.4 Bil
Fresenius SE & Co KGaA
FSNUF
Lwpwf$18.4 Bil
Tenet Healthcare Corp
THC
PhlfxnmhZtqq$13.0 Bil
Universal Health Services Inc Class B
UHS
Gtlnf$12.1 Bil
DaVita Inc
DVA
HdmwgdwLthfpsh$12.1 Bil
Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt
BDUUF
Wnh$11.7 Bil
Bangkok Dusit Medical Services PCL Shs Foreign Registered
BDULF
Dsbm$11.7 Bil
Fresenius Medical Care AG ADR
FMS
CvrxXxkds$11.6 Bil
AMN Healthcare Services Inc
AMN
RgzycdsFmrwqc$2.2 Bil

Sponsor Center